tm logo
ERFLOVO
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 08 Jun 2020

Last Applicant/ Owned by

Gewerbestrasse 16

Allschwil

CH

4123

Serial Number

87641464 filed on 11th Oct 2017

Registration Number

N/A

Correspondent Address

Cheryl Foytlin

Cheryl Foytlin

ONE JOHNSON & JOHNSON PLAZA

NEW BRUNSWICK NJ 08933

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ERFLOVO

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infection-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; Read More

Classification Information


Class [005]
Pharmaceutical Products


Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infection-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; anti-allergics; vaccines

Mark Details


Serial Number

No 87641464

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T41822US2

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
08th Jun 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
08th Jun 2020ABANDONMENT - NO USE STATEMENT FILED
31st Aug 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29th Aug 2019EXTENSION 3 FILED
29th Aug 2019EXTENSION 3 GRANTED
29th Aug 2019TEAS EXTENSION RECEIVED
01st Mar 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27th Feb 2019TEAS EXTENSION RECEIVED
27th Feb 2019EXTENSION 2 FILED
27th Feb 2019EXTENSION 2 GRANTED